Ted Ebendal

Title: The Innovations of Ted Ebendal

Introduction

Ted Ebendal is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of neurobiology through his innovative research and patents. With a total of 3 patents, his work focuses on the synergistic effects of morphogens and neurotrophic factors in promoting cell survival and growth.

Latest Patents

Ebendal's latest patents include groundbreaking research on the synergistic effects of OP/BMP morphogens and GDNF/NGF neurotrophic factors. His findings suggest that OP/BMP morphogens can be combined with GDNF/NGF neurotrophic factors to enhance the survival or growth of mammalian cells, particularly neural cells. These cells express OP/BMP-activated serine/threonine kinase receptors and GDNF/NGF-activated tyrosine kinase receptors. The patents also disclose methods for treating cells at risk of damage or injury, along with new pharmaceutical preparations for such treatments.

Career Highlights

Throughout his career, Ted Ebendal has worked with various companies, including Curis, Inc. and Scion Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise in the field of neurobiology and the development of innovative treatments.

Collaborations

Ebendal has collaborated with notable coworkers such as Marc F. Charette and David C. Rueger. These collaborations have further enriched his research and contributed to the advancement of his innovative ideas.

Conclusion

Ted Ebendal's contributions to the field of neurobiology through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of treatments for neural cell damage and degeneration.